content: <HTML>
  <HEAD>
  <TITLE></TITLE>
  </HEAD>
  <BODY STYLE="font-size: 10pt">
  
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">SECURITIES AND EXCHANGE
  COMMISSION</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">Washington, D.C. 20549</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center; font-size: 12pt; font-weight: bold">FORM 8-K</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">CURRENT REPORT</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">Pursuant to Section 13 or 15(d)</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">of the Securities Exchange Act of 1934</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">Date of Report (date of earliest event
  reported):</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">September 21, 2015</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
  <TR STYLE="background-color: white">
      <TD COLSPAN="5" STYLE="margin-top: 0; margin-bottom: 0; text-align: center; border-bottom: Black 1pt solid; font-size: 12pt"><FONT STYLE="line-height: 115%"><B>EVENT
      CARDIO GROUP INC.</B></FONT></TD></TR>
  <TR STYLE="background-color: white">
      <TD COLSPAN="5" STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="line-height: 115%">(Exact
      name of registrant as specified in its charter)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="margin-top: 0; margin-bottom: 0; text-align: center; width: 34%; border-bottom: Black 1pt solid"><FONT STYLE="line-height: 115%"><B>Nevada</B></FONT></TD>
      <TD STYLE="margin-top: 0; margin-bottom: 0; text-align: center; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
      <TD STYLE="margin-top: 0; margin-bottom: 0; text-align: center; width: 30%; border-bottom: Black 1pt solid"><FONT STYLE="line-height: 115%"><B>0-52518</B></FONT></TD>
      <TD STYLE="margin-top: 0; margin-bottom: 0; text-align: center; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
      <TD STYLE="margin-top: 0; margin-bottom: 0; text-align: center; width: 34%; border-bottom: Black 1pt solid"><FONT STYLE="line-height: 115%"><B>20-8051714</B></FONT></TD></TR>
  <TR STYLE="text-align: center; vertical-align: top">
      <TD STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="line-height: 115%">(State or other jurisdiction
      of Incorporation)</FONT></TD>
      <TD STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</TD>
      <TD STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="line-height: 115%">(Commission File Number)</FONT></TD>
      <TD STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</TD>
      <TD STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="line-height: 115%">(I.R.S. Employer Identification
      No.)</FONT></TD></TR>
  </TABLE>
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 45%; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B>2798 Thamesgate Dr.</B></P>
          <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B>Mississauga, Ontario, Canada</B></P></TD>
      <TD STYLE="margin-top: 0; margin-bottom: 0; text-align: center; width: 10%; padding-bottom: 1pt">&nbsp;</TD>
      <TD STYLE="margin-top: 0; margin-bottom: 0; text-align: center; width: 45%; border-bottom: Black 1pt solid"><FONT STYLE="line-height: 115%"><B>L4T
      4E8</B></FONT></TD></TR>
  </TABLE>
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">Check the appropriate box below if the
  Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
  (see General Instruction A.2. below):</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">[ ] Written communications pursuant to Rule 425 under
  the Securities Act (17 CFR 230.425)</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">[ ] Soliciting material pursuant to Rule 14a-12 under
  the Exchange Act (17&nbsp;&nbsp;&nbsp;CFR 240.14a-12)</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">[ ] Pre-commencement communications pursuant to Rule
  14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">[ ] Pre-commencement communications pursuant to Rule 13e-4(c)
  under the Exchange Act (17 CFR 240.13e-4(c))&nbsp;</P>
  
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify"><B>Item 3.02 Sale of Unregistered Securities.</B></P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify; text-indent: 20pt">The Company has consummated Subscription
  Agreements with five investors whereby it received an aggregate of $205,000, inclusive of the $185,000 which it announced in a
  press release dated September 8, 2015. The investors include a Partner of counsel to the Company, a non-affiliated shareholder
  who previously invested in excess of $100,000 in the Company and three individuals affiliated with MedPac Asia Pacific Pty. Ltd.,
  the Australian entity which previously acquired the exclusive right to distribute the Company&#8217;s Now Cardio&#8482; and BreastCare
  DTS in Australia and certain countries in Southeast Asia. In consideration for the $210,000, the investors received an aggregate
  of 4,100,000 shares of the Company&#8217;s common stock and warrants to purchase 4,100,000 shares of the Company&#8217;s common
  stock exercisable for a period of approximately four years at ten cents ($0.10) per share.</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify; text-indent: 20pt">The issuance and sale of the shares
  of common stock and warrants to the two investors located within the United States were exempt from the registration requirements
  of the Securities Act of 1933 under Rule 506 of Regulation D. Each of the investors is an accredited investor within the meaning
  of Rule 501(a) of Regulation D. The balance of the investors were not &#8220;U.S. Persons&#8221; as defined in Regulation S promulgated
  under the Securities Act. The sales to such persons were made in &#8220;Offshore Transactions&#8221; and were exempt from the
  registration requirements of the Securities Act pursuant to Regulation S. The Company agreed to issue to MedPac Asia Pacific Pty.
  Ltd 320,000 shares of its common stock for coordinating the sales to the Australian investors. A legend restricting the sale,
  transfer or other disposition of the securities issued to the investors and Medpac other than pursuant to registration under the
  Securities Act or an exemption therefrom was imprinted on the certificates evidencing the securities.</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify"><B>Item&nbsp;9.01</B> <B>&nbsp;Financial Statements and Exhibits.</B></P>
  
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify"><B>(d)</B> <B>Exhibits.</B></P>
  
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 8%; border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><P STYLE="margin-top: 0; margin-bottom: 0"><B>Exhibit</B></P>
          <P STYLE="margin-top: 0; margin-bottom: 0"><B>Number</B></P></TD>
      <TD STYLE="margin-top: 0; margin-bottom: 0; text-align: justify; width: 5%; padding-bottom: 1pt">&nbsp;</TD>
      <TD STYLE="margin-top: 0; margin-bottom: 0; text-align: justify; width: 87%; border-bottom: Black 1pt solid"><B>Description</B></TD></TR>
  <TR>
      <TD STYLE="margin-top: 0; margin-bottom: 0; text-align: center; vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</TD>
      <TD STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="margin-top: 0; margin-bottom: 0; text-align: center; vertical-align: bottom">10.1</TD>
      <TD STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify"><A HREF="ecgi8k092315ex10_1.htm">Form of Subscription Agreement between the Company and the U. S. Investors</A></P></TD></TR>
  <TR>
      <TD STYLE="margin-top: 0; margin-bottom: 0; text-align: center; vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  
  <TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: center; vertical-align: bottom">10.2</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><A HREF="ecgi8k092315ex10_2.htm">Form of Subscription Agreement between the Company and the Australian Investors</A></TD>
  </TR>     <TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
  
  <TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: center; vertical-align: bottom">10.3</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><A HREF="ecgi8k092315ex10_3.htm">Form of Warrant issued to the U. S. Investors.</A></TD>
  </TR>     <TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
  
  <TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: center; vertical-align: bottom">10.4</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><A HREF="ecgi8k092315ex10_4.htm">Form of Warrant issued to the Australian Investors.</A></TD>
  </TR></TABLE>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">SIGNATURES</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify; text-indent: 20pt">Pursuant to the requirements of the Securities
  Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify; text-indent: 20pt">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="line-height: 115%">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="line-height: 115%">EVENT CARDIO GROUP INC.</TD>
      <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 52%; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 2%; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 35%; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 11%; line-height: 115%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="line-height: 115%">Dated: September 23, 2015</TD>
      <TD STYLE="line-height: 115%">By:</TD>
      <TD STYLE="border-bottom: black 1.5pt solid; line-height: 115%">/s/&nbsp;John Bentivoglio</TD>
      <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; line-height: 115%">&nbsp;</TD>
      <TD STYLE="vertical-align: top; line-height: 115%">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; line-height: 115%">John Bentivoglio</TD>
      <TD STYLE="vertical-align: top; line-height: 115%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="line-height: 115%">&nbsp;</TD>
      <TD STYLE="line-height: 115%">&nbsp;</TD>
      <TD STYLE="line-height: 115%">Chief Executive Officer</TD>
      <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
  </TABLE>
  <P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>
  
  <!-- Field: Page; Sequence: 2; Options: Last -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>
  
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "ecgi8k092315.htm", "secsgml_size_bytes": 13754}]
metadata_filer: {"company-data": {"conformed-name": "Event Cardio Group Inc.", "cik": "0001394130", "assigned-sic": "1000", "irs-number": "208051714", "state-of-incorporation": "NV", "fiscal-year-end": "0831"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-52518", "film-number": "151123612"}, "business-address": {"street1": "2798 THAMESGATE DR.", "city": "MISSISSAUGA", "state": "A6", "zip": "L4T 4E8", "phone": "289-407-4377"}, "mail-address": {"street1": "2798 THAMESGATE DR.", "city": "MISSISSAUGA", "state": "A6", "zip": "L4T 4E8"}, "former-company": [{"former-conformed-name": "Sunrise Holdings LTD", "date-changed": "20080404"}, {"former-conformed-name": "Sunrise Mining CORP", "date-changed": "20070322"}]}
text: SECURITIES AND EXCHANGE
  COMMISSION
  Washington, D.C. 20549
  FORM 8-K
  CURRENT REPORT
  Pursuant to Section 13 or 15(d)
  of the Securities Exchange Act of 1934
  Date of Report (date of earliest event
  reported):
  September 21, 2015
  EVENT
      CARDIO GROUP INC.
  (Exact
      name of registrant as specified in its charter)
  Nevada
  0-52518
  20-8051714
  (State or other jurisdiction
      of Incorporation)
  (Commission File Number)
  (I.R.S. Employer Identification
      No.)
  2798 Thamesgate Dr.
  Mississauga, Ontario, Canada
  L4T
      4E8
  Check the appropriate box below if the
  Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
  (see General Instruction A.2. below):
  [ ] Written communications pursuant to Rule 425 under
  the Securities Act (17 CFR 230.425)
  [ ] Soliciting material pursuant to Rule 14a-12 under
  the Exchange Act (17   CFR 240.14a-12)
  [ ] Pre-commencement communications pursuant to Rule
  14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [ ] Pre-commencement communications pursuant to Rule 13e-4(c)
  under the Exchange Act (17 CFR 240.13e-4(c))
  Item 3.02 Sale of Unregistered Securities.
  The Company has consummated Subscription
  Agreements with five investors whereby it received an aggregate of $205,000, inclusive of the $185,000 which it announced in a
  press release dated September 8, 2015. The investors include a Partner of counsel to the Company, a non-affiliated shareholder
  who previously invested in excess of $100,000 in the Company and three individuals affiliated with MedPac Asia Pacific Pty. Ltd.,
  the Australian entity which previously acquired the exclusive right to distribute the Company's Now Cardio™ and BreastCare
  DTS in Australia and certain countries in Southeast Asia. In consideration for the $210,000, the investors received an aggregate
  of 4,100,000 shares of the Company's common stock and warrants to purchase 4,100,000 shares of the Company's common
  stock exercisable for a period of approximately four years at ten cents ($0.10) per share.
  The issuance and sale of the shares
  of common stock and warrants to the two investors located within the United States were exempt from the registration requirements
  of the Securities Act of 1933 under Rule 506 of Regulation D. Each of the investors is an accredited investor within the meaning
  of Rule 501(a) of Regulation D. The balance of the investors were not "U.S. Persons" as defined in Regulation S promulgated
  under the Securities Act. The sales to such persons were made in "Offshore Transactions" and were exempt from the
  registration requirements of the Securities Act pursuant to Regulation S. The Company agreed to issue to MedPac Asia Pacific Pty.
  Ltd 320,000 shares of its common stock for coordinating the sales to the Australian investors. A legend restricting the sale,
  transfer or other disposition of the securities issued to the investors and Medpac other than pursuant to registration under the
  Securities Act or an exemption therefrom was imprinted on the certificates evidencing the securities.
  Item 9.01
  Financial Statements and Exhibits.
  (d)
  Exhibits.
  Exhibit
  Number
  Description
  10.1
  Form of Subscription Agreement between the Company and the U. S. Investors
  10.2
  Form of Subscription Agreement between the Company and the Australian Investors
  10.3
  Form of Warrant issued to the U. S. Investors.
  10.4
  Form of Warrant issued to the Australian Investors.
  SIGNATURES
  Pursuant to the requirements of the Securities
  Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  EVENT CARDIO GROUP INC.
  Dated: September 23, 2015
  By:
  /s/ John Bentivoglio
  John Bentivoglio
  Chief Executive Officer